Search

everythinglearnresearchcommunity

for

Search:↓

New 5% minoxidil foam effectively promotes hair growth and is safe for use.

2% topical minoxidil effectively treats female hair loss with minimal side effects.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Minoxidil helps hair growth and reduces shedding in women.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

The document concludes that topical minoxidil therapy is safe and effective in promoting hair growth for male pattern baldness.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Hair loss gradually happens, and minoxidil helps regrow hair.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Hair loss affects women's mental health more than men's, causing anxiety, low self-esteem, and social insecurity.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Hair loss needs more research for better treatments.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Low iron levels may be linked to some types of hair loss in women.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Hair loss linked to higher heart disease risk in both men and women.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Mice without the vitamin D receptor gene lose hair due to disrupted hair follicle cycles.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Chinese men have lower AGA rates than Caucasians, with type III vertex most common; family history is important.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.